References
- CIBIS-II Investigation and CommitteeThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialLancet199935391310023943
- GhaliJKPiñaILGottliebSSMetoprolol CR/XL in female patients with heart failure: analysis of the experience in metoprolol extended-release randomized intervention trial in heart failure (MERIT-HF)Circulation200210515859111927527
- GoldsteinSFagerbergBHjalmarsonÅMetoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF studyJ Am Coll Cardiol200138932811583861
- GottliebSSFisherMLKjekshusJTolerability of beta-blocker initiation and titration in the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)Circulation20021051182811889011
- HamadASalamehMZihlifMLife-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patientAm J Nephrol200121241411423696
- HjalmarsonÅGoldsteinSFagerbergBEffects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failureJAMA2000283129530210714728
- JuurlinkDNMamdaniMMLeeDSRates of hyperkalemia after publication of the Randomized Aldactone Evaluation StudyN Engl J Med20043515435115295047
- KomajdaMLapuertaPHermansNAdherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER surveyEur Heart J2005 April 12 [Epub ahead of print]
- MERIT-HF Study GroupEffect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)Lancet19993532001710376614
- PackerMBristowMRCohnJNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failureN Engl J Med19963341349558614419
- PackerMCoatsAJSFowlerMBEffect of carvedilol on survival in severe chronic heart failureN Engl J Med20013441651811386263
- SwensonERSevere hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonistArch Intern Med1986146122013718111
- TabrizchiRShould β-blockers form the cornerstone for the treatment of congestive heart failure?Expert Rev Cardiovasc Ther200311576015030275
- TamirisaKPAaronsonKDKoellingTMSpironolactone-induced renal insufficiency and hyperkalemia in patients with heart failureAm Heart J2004148971815632880
- The RALES InvestigatorsEffectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])Am J Cardiol19967890278888663
- The Study Group of Diagnosis of the Working Group on Heart Failure the European Society of CardiologyThe EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in EuropeEur Heart J2003244647412633547
- WikstrandJHjalmarsonÅWaagsteinFDose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)J Am Coll Cardiol200240491812142116